Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;10(1):21-7.
doi: 10.3969/j.issn.1671-5411.2013.01.005.

Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery disease

Xian-Feng Liu  1 , Jian Cao, Li Fan, Lin Liu, Jian Li, Guo-Liang Hu, Yi-Xin Hu, Xiao-Li Li
Affiliations

Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery disease

Xian-Feng Liu et al. J Geriatr Cardiol. 2013 Mar.

Abstract

Objective: To assess the prevalence of and related risk factors for aspirin resistance in elderly patients with coronary artery disease (CAD).

Methods: Two hundred and forty-six elderly patients (75.9 ± 7.4 years) with CAD who received daily aspirin therapy (≥ 75 mg) over one month were recruited. The effect of aspirin was assessed using light transmission aggregometry (LTA) and thrombelastography platelet mapping assay (TEG). Aspirin resistance was defined as ≥ 20% arachidonic acid (AA)-induced aggregation and ≥ 70% adenosine diphosphate (ADP)-induced aggregation in the LTA assay. An aspirin semi-responder was defined as meeting one (but not both) of the criteria described above. Based on the results of TEG, aspirin resistance was defined as ≥ 50% aggregation induced by AA.

Results: As determined by LTA, 23 (9.3%) of the elderly CAD patients were resistant to aspirin therapy; 91 (37.0%) were semi-responders. As determined by TEG, 61 patients (24.8%) were aspirin resistant. Of the 61 patients who were aspirin resistant by TEG, 19 were aspirin resistant according to LTA results. Twenty-four of 91 semi-responders by LTA were aspirin resistant by TEG. Multivariate logistic regression analysis revealed that elevated fasting serum glucose level (Odds ratio: 1.517; 95% CI: 1.176-1.957; P = 0.001) was a significant risk factor for aspirin resistance as determined by TEG.

Conclusions: A significant number of elderly patients with CAD are resistant to aspirin therapy. Fasting blood glucose level is closely associated with aspirin resistance in elderly CAD patients.

Keywords: Aspirin resistance; Coronary artery disease; Risk factors.

PubMed Disclaimer

References

    1. Cohen J. The global burden of disease study: A useful projection of future global health? J Public Health Med. 2000;22:518–524. - PubMed
    1. Centers for Disease Control and Prevention (CDC) Prevalence of coronary heart disease--united states, 2006–2010. MMWR Morb Mortal Wkly Rep. 2011;60:1377–1381. - PubMed
    1. Antithrombotic Trialists' Collaboration Collaborative meta- analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86. - PMC - PubMed
    1. Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: Implications of aspirin resistance. J Am Coll Cardiol. 2008;51:1829–1843. - PubMed
    1. Crescente M, Di Castelnuovo A, Iacoviello L, et al. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost. 2008;99:14–26. - PubMed

LinkOut - more resources